These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 20005724)
21. Autotaxin promotes cancer invasion via the lysophosphatidic acid receptor 4: participation of the cyclic AMP/EPAC/Rac1 signaling pathway in invadopodia formation. Harper K; Arsenault D; Boulay-Jean S; Lauzier A; Lucien F; Dubois CM Cancer Res; 2010 Jun; 70(11):4634-43. PubMed ID: 20484039 [TBL] [Abstract][Full Text] [Related]
22. Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid. Inoue M; Xie W; Matsushita Y; Chun J; Aoki J; Ueda H Neuroscience; 2008 Mar; 152(2):296-8. PubMed ID: 18280050 [TBL] [Abstract][Full Text] [Related]
23. Autotaxin and lysophospholipids in rheumatoid arthritis. Bourgoin SG; Zhao C Curr Opin Investig Drugs; 2010 May; 11(5):515-26. PubMed ID: 20419597 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of inhibitory actions of flavonols and related substances on lysophospholipase d activity of serum autotaxin by a convenient assay using a chromogenic substrate. Ueda K; Yoshihara M; Nakao M; Tanaka T; Sano S; Fukuzawa K; Tokumura A J Agric Food Chem; 2010 May; 58(10):6053-63. PubMed ID: 20415488 [TBL] [Abstract][Full Text] [Related]
25. A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation. Gierse J; Thorarensen A; Beltey K; Bradshaw-Pierce E; Cortes-Burgos L; Hall T; Johnston A; Murphy M; Nemirovskiy O; Ogawa S; Pegg L; Pelc M; Prinsen M; Schnute M; Wendling J; Wene S; Weinberg R; Wittwer A; Zweifel B; Masferrer J J Pharmacol Exp Ther; 2010 Jul; 334(1):310-7. PubMed ID: 20392816 [TBL] [Abstract][Full Text] [Related]
26. Autotaxin is induced by TSA through HDAC3 and HDAC7 inhibition and antagonizes the TSA-induced cell apoptosis. Li S; Wang B; Xu Y; Zhang J Mol Cancer; 2011 Feb; 10():18. PubMed ID: 21314984 [TBL] [Abstract][Full Text] [Related]
27. Lipopolysaccharide induces autotaxin expression in human monocytic THP-1 cells. Li S; Zhang J Biochem Biophys Res Commun; 2009 Jan; 378(2):264-8. PubMed ID: 19027716 [TBL] [Abstract][Full Text] [Related]
28. Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Clair T; Aoki J; Koh E; Bandle RW; Nam SW; Ptaszynska MM; Mills GB; Schiffmann E; Liotta LA; Stracke ML Cancer Res; 2003 Sep; 63(17):5446-53. PubMed ID: 14500380 [TBL] [Abstract][Full Text] [Related]
29. The cellular localization of autotaxin impacts on its biological functions in human thyroid carcinoma cells. Seifert A; Klonisch T; Wulfaenger J; Haag F; Dralle H; Langner J; Hoang-Vu C; Kehlen A Oncol Rep; 2008 Jun; 19(6):1485-91. PubMed ID: 18497954 [TBL] [Abstract][Full Text] [Related]
30. Efficient synthesis of 3-O-thia-cPA and preliminary analysis of its biological activity toward autotaxin. Tanaka R; Kato M; Suzuki T; Nakazaki A; Nozaki E; Gotoh M; Murakami-Murofushi K; Kobayashi S Bioorg Med Chem Lett; 2011 Jul; 21(14):4180-2. PubMed ID: 21676615 [TBL] [Abstract][Full Text] [Related]
31. Functional invalidation of the autotaxin gene by a single amino acid mutation in mouse is lethal. Ferry G; Giganti A; Cogé F; Bertaux F; Thiam K; Boutin JA FEBS Lett; 2007 Jul; 581(18):3572-8. PubMed ID: 17628547 [TBL] [Abstract][Full Text] [Related]
32. Phosphodiesterase-Ialpha/autotaxin (PD-Ialpha/ATX): a multifunctional protein involved in central nervous system development and disease. Dennis J; Nogaroli L; Fuss B J Neurosci Res; 2005 Dec; 82(6):737-42. PubMed ID: 16267828 [TBL] [Abstract][Full Text] [Related]
33. Autotaxin: a protein with two faces. Tania M; Khan MA; Zhang H; Li J; Song Y Biochem Biophys Res Commun; 2010 Oct; 401(4):493-7. PubMed ID: 20888793 [TBL] [Abstract][Full Text] [Related]
34. Diadenosine 5',5''-(boranated)polyphosphonate analogues as selective nucleotide pyrophosphatase/phosphodiesterase inhibitors. Eliahu S; Lecka J; Reiser G; Haas M; Bigonnesse F; Lévesque SA; Pelletier J; Sévigny J; Fischer B J Med Chem; 2010 Dec; 53(24):8485-97. PubMed ID: 21090681 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of autotaxin production or activity blocks lysophosphatidylcholine-induced migration of human breast cancer and melanoma cells. Gaetano CG; Samadi N; Tomsig JL; Macdonald TL; Lynch KR; Brindley DN Mol Carcinog; 2009 Sep; 48(9):801-9. PubMed ID: 19204929 [TBL] [Abstract][Full Text] [Related]
36. Discovery and synthetic optimization of a novel scaffold for hydrophobic tunnel-targeted autotaxin inhibition. Ragle LE; Palanisamy DJ; Joe MJ; Stein RS; Norman DD; Tigyi G; Baker DL; Parrill AL Bioorg Med Chem; 2016 Oct; 24(19):4660-4674. PubMed ID: 27544588 [TBL] [Abstract][Full Text] [Related]
37. Autotaxin (lysoPLD/NPP2) protects fibroblasts from apoptosis through its enzymatic product, lysophosphatidic acid, utilizing albumin-bound substrate. Song J; Clair T; Noh JH; Eun JW; Ryu SY; Lee SN; Ahn YM; Kim SY; Lee SH; Park WS; Yoo NJ; Lee JY; Nam SW Biochem Biophys Res Commun; 2005 Nov; 337(3):967-75. PubMed ID: 16219296 [TBL] [Abstract][Full Text] [Related]
38. Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain. Inoue M; Ma L; Aoki J; Chun J; Ueda H Mol Pain; 2008 Feb; 4():6. PubMed ID: 18261210 [TBL] [Abstract][Full Text] [Related]
39. Autotaxin (ATX): a multi-functional and multi-modular protein possessing enzymatic lysoPLD activity and matricellular properties. Yuelling LM; Fuss B Biochim Biophys Acta; 2008 Sep; 1781(9):525-30. PubMed ID: 18485925 [TBL] [Abstract][Full Text] [Related]